Morgan Stanley Finance files free writing prospectus for notes
Morgan Stanley Finance LLC has filed a free writing prospectus for market-linked notes due November 29, 2030, indicating a focus on innovative financial products.
Morgan Stanley Capital I Trust 2019-L2 Files Latest ABS Report
Morgan Stanley Capital I Trust 2019-L2 updates on its asset-backed securities, showcasing stability in its commercial mortgage portfolio.
True Life Companies Elite Fund I amends offering details
True Life Companies Elite Fund I, LP amends its offering with $150 million total, $100 million sold, and a minimum investment of $100,000.
BlackRock Advantage Global Fund Updates Investor Prospectus
BlackRock Advantage Global Fund, Inc. updates its prospectus, detailing investment objectives and fees, reflecting changes in the investment landscape.
EquityZen Growth Technology Fund raises $619,473 in offering
EquityZen Growth Technology Fund LLC - Series 2415 successfully raises $619,473 through a private equity offering, signaling growth in the investment sector.
Morgan Stanley files free writing prospectus for new notes
Morgan Stanley has filed a free writing prospectus for SPX Market-Linked Notes due 2029, expanding its investment offerings.
JPMorgan Chase issues $1.177 million in callable notes
JPMorgan Chase & Co. issues callable fixed-rate notes worth $1.177 million, maturing in 2046, highlighting its investment strategy amid industry competition.
JPMorgan Chase issues $3.1M callable fixed-rate notes due 2038
JPMorgan Chase & Co. files for $3.1 million in callable fixed-rate notes, signaling a strategic move in the competitive national commercial banking sector.
Kelly Aengus to Sell 60,000 Shares of AerCap Holdings
Kelly Aengus files to sell 60,000 shares of AerCap Holdings, signaling a liquidity move valued at $9.58 million. Insights into the equipment rental sector emerge.
Shelton Funds reports financials in latest NPORT-P filing
Shelton Funds releases its latest financial report, detailing significant assets and liabilities in the investment sector.
Growth Fund of America Files Summary Prospectus Update
Growth Fund of America files a summary prospectus detailing investment objectives and fees, impacting investors and the investment management industry.
Morgan Stanley Finance files free writing prospectus for notes
Morgan Stanley Finance LLC has filed a free writing prospectus for market-linked notes due November 29, 2029, targeting investors in the securities sector.
Morgan Stanley Capital I Trust 2019-L2 Reports October 2026 Results
Morgan Stanley Capital I Trust 2019-L2 shares its October 2026 distribution report, revealing key performance metrics in the asset-backed securities market.
Short-Term Bond Fund of America files new registration statement
Short-Term Bond Fund of America has filed a new registration statement, reflecting its ongoing commitment to adapt to market conditions.
MTLTD a Series of CGF2026 LLC raises $142,000 in equity fund
MTLTD a Series of CGF2026 LLC successfully raises $142,000 in a private equity fund offering, marking a significant step in its investment strategy.
BlackRock Advantage Global Fund Updates Prospectus for Class K
BlackRock Advantage Global Fund, Inc. updates its prospectus for Class K shares, detailing investment strategies and expenses, enhancing investor transparency.
Morgan Stanley Files Free Writing Prospectus for Callable Notes
Morgan Stanley's latest filing reveals new callable jump notes, showcasing its strategy to innovate within the security brokers and dealers sector.
Shelton Funds Reports Financials in Latest NPORT-P Filing
Shelton Funds discloses financials in NPORT-P filing, showing $115.85 million in assets as of August 31, 2026, highlighting its position in the investment sector.
GS Finance Corp. files for $69.95M callable yield notes
GS Finance Corp. seeks to raise $69.95 million through callable contingent yield notes, backed by Goldman Sachs Group, indicating strong market confidence.
Vanguard Capital Management reveals 5.16% stake in Palisade Bio
Vanguard Capital Management LLC discloses a 5.16% ownership in Palisade Bio, Inc., signaling its investment strategy in the biological products sector.